MétaCan
Menu
← Back to cohort
Record W4248153717 · doi:10.1093/neuonc/nox083.163

MEDU-12. CD271 (P75NTR) AS A NOVEL DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR SHH MEDULLOBLASTOMA

2017· article· en· W4248153717 on OpenAlexaff
Lisa Liang, Ludivine Coudière-Morrison, Nazanin Tatari, Vijay Ramaswamy, Timothy C. Ryken, Marc R. Del Bigio, Cynthia Hawkins, Jennifer A. Chan, Tamra E. Werbowetski‐Ogilvie

Bibliographic record

VenueNeuro-Oncology · 2017
Typearticle
Languageen
FieldMedicine
TopicSarcoma Diagnosis and Treatment
Canadian institutionsUniversity of CalgaryHospital for Sick ChildrenUniversity of Manitoba
Fundersnot available
KeywordsLow-affinity nerve growth factor receptorBiologyCancer researchWnt signaling pathwayCell biologySignal transductionNeurotrophinReceptorGenetics

Abstract

fetched live from OpenAlex

Medulloblastoma (MB) is the most common malignant primary brain tumor and is currently classified into 5 distinct molecular subtypes based on genomic alterations, gene expression profile, response to treatment and cell of origin. This extensive heterogeneity has revealed a critical need for subtype-specific, functionally validated biomarkers and therapeutic strategies. Using an unbiased high throughput flow cytometry screen and gain/loss of function studies, we previously identified CD271/p75NTR as a candidate stem/progenitor cell marker, specifically in SHH MB. Here, we show that CD271+ and CD271- subpopulations do not exhibit a hierarchal organization; but are rather two co-existing cellular subsets. FACS sorting followed by re-culturing of CD271- and CD271+ cells from low passage primary cultures demonstrated that both cell populations can recapitulate the parental phenotype. However, global gene expression profiling by RNA sequencing revealed that genes/pathways associated with cell survival, proliferation and motility are downregulated in CD271- vs. CD271+ subpopulations. Cell cycle analysis supported these findings and demonstrated that CD271- cells exhibited a decrease in proliferation compared to CD271+ cells. Moreover, PI3K/AKT, JAK/STAT, and NFkB, are downregulated in CD271- vs. CD271+ cells, while pathways such as RAS/MYC are upregulated in CD271- vs. CD271+ cells. Immunohistochemical (IHC) analysis of CD271 levels across the MB subtypes demonstrated that nearly all SHH tumors express CD271, while Group 3 tumors exhibit moderate staining. In contrast, Group 4 MB and WNT do not express CD271. Importantly SHH MB exhibit a nodular CD271 staining pattern, further underscoring the heterogeneity within these tumors and supporting our findings that CD271- and CD271+ cells are distinct, yet clinically relevant, subpopulations. Our results suggest that CD271, in combination with other markers, could be effectively utilized as a diagnostic tool for SHH MB and that therapeutic strategies concomitantly targeting both CD271+ and CD271- subpopulations would be the most effective in SHH MB treatment.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.035
GPT teacher head0.331
Teacher spread0.296 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-Oncology→Same topicSarcoma Diagnosis and Treatment→French-language works237,207→